fbpx

Preparation and Integration for Psychedelic Journeys

Log in to view the recording.

*Exclusive for members.

Thursday, October 28th at 5 pm Pacific, 8 pm Eastern >> Watch now >>

Join Us For an EXCLUSIVE Panel Discussion for Members of The Psychedelic Medicine Association:

Preparation and Integration for Psychedelic Journeys

Panel Moderator:

Rebecca Kronman, LCSW

LCSW is a licensed therapist and founder of Plant Parenthood.

Rebecca Kronman, LCSW is a licensed therapist and founder of Plant Parenthood, a digital and
in-person community of parents who use psychedelics. She is also an assisting trainer with
Fluence, a company that trains healthcare practitioners in harm reduction informed psychedelic
preparation and integration. At her private practice in Brooklyn, she works with creative
professionals using mindfulness and experiential techniques to address depression, anxiety and
life transitions. She also helps clients prepare for psychedelic experiences, incorporate insights
or cope with challenges post-experience. Selected trainings include Mindfulness Based Stress
Reduction, Mindfulness for Clinicians, Psychedelics 101 & 102 and Beyond Experience
Psychedelic Integration Workshop.

Panelists:

Devon Christie, MD RTC

VP, Clinical and Therapeutic Services, with Numinus Wellness

Dr. Devon Christie is VP, Clinical and Therapeutic Services, with Numinus Wellness Inc., a company creating an ecosystem of health solutions centered around safe, evidence-based, accessible use of psychedelic-assisted psychotherapies. She is a both a family doctor and Registered Therapeutic Counsellor, with a focused practice in Chronic Pain, and emphasis in Relational Somatic Therapy for trauma resolution. Additionally, she is a MAPS-trained therapist for MDMA-assisted psychotherapy, certified Mindfulness-Based Stress Reduction (MBSR) teacher, and Functional Medicine Practitioner. Devon is an instructor in the CIIS Certificate in Psychedelic-assisted Therapies and Research post-graduate program.

Alli Feduccia, PhD

Co-Founder of Psychedelic.Support and Project New Day

Allison Feduccia, PhD is a neuropharmacologist, psychedelic researcher, and a builder of virtual and in-person communities. She is the Co-Founder of Psychedelic.Support and Project New Day. In these roles, Dr. Feduccia facilitates the spreading of evidence-based knowledge, connection to resources, and strategies for individuals to maximize the potential therapeutic benefits of psychedelics through safe and responsible practices. She began researching MDMA in 2004 and has worked on studies of psychedelics and mental health conditions at universities, NIH, and MAPS.

Hannah McLane, MD, MA, MPH

Founder of SoundMind

Hannah McLane MD, MA, MPH is a physician, psychotherapist, and entrepreneur. She is the founder and clinical director of the SoundMind Center, a psychedelic therapy center and nonprofit in West Philadelphia, aimed at providing accessible and inclusive psychedelic care and education. She teaches psychedelic therapy training courses and has trained over 125 therapists and clinicians. She conducts research which focuses on cognitive diversity, psychedelic science, ethics, PTSD, and emerging alternative therapies for mental health issues. She also has a background in teaching meditation and has participated in numerous silent retreats over the past two decades. Information about her course and clinic can be found at www.soundmind.cente

Dr. McLane holds degrees from McGill University (BA, International Development Studies), Temple University (MA, Communication Sciences), Brown University (MD, Doctor of Medicine), and Harvard School of Public Health (MPH, Global health and Bioethics). Her residency experiences include neurology and Occupational and Environmental Medicine (University of Pennsylvania). Her post-residency training includes postdoc fellowship in Patient Safety (VA Medical Center, Philadelphia), psychoanalytic training (PCOP), and MDMA-Assisted-Psychotherapy training (MAPS).

As you’ve probably heard, psychedelic medicine is so much more than the actual substances themselves. While it’s not impossible to derive benefit from an isolated consumption of a psychedelic substance, for patients to get the most out of their psychedelic therapies, it’s crucial that there be preparation for the journey beforehand and integration afterward.

But what exactly does that entail? And who is trained to do this kind of work?

To answer those questions, we are honored to have panelists on this month’s webinar to cover:

  • Why preparation/integration are important
  • What preparation for a psychedelic journey entails
  • What integration can look like
  • Who is trained to do preparation/integration
  • How to know when a patient’s preparation or integration course are complete enough to end formal sessions

…and much more!

As always, there will be ample time for audience Q & A, so you’ll get to interact with the panelists directly!

So please join us for this live panel discussion on Thursday, October 28th at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. And for members, please register for the panel here. A link to the recording will be available afterward if you cannot make it to the live event.

Hope to see you all on the 28th!

You can find the Psychedelic Medicine Association on Twitter, LinkedIn, and on Facebook.